{"id":211613,"name":"VIR BIOTECHNOLOGY, INC.","slug":"vir-biotechnology-inc","state":"CA","country":"United States of America","description":"","totalSpending":1400000,"filings":11,"yearlySpending":[{"year":2021,"income":290000},{"year":2022,"income":600000},{"year":2023,"income":510000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"SCI","display":"Science/Technology"},{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"TRD","display":"Trade (domestic/foreign)"}],"firms":["VIR BIOTECHNOLOGY, INC."],"lobbyists":["DOUGLAS STOSS"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","Office of Science & Technology Policy (OSTP)","SENATE","Natl Institutes of Health (NIH)","Natl Security Council (NSC)","U.S. International Trade Commission (ITC)","White House Office","Centers For Disease Control & Prevention (CDC)"],"sampleDescriptions":["BARDA/DoD Procurements, COVID-19 Response, Pandemic Preparedness, Rx Policy in Budget Reconciliation","BARDA/DoD Procurements, COVID-19 Response, Pandemic Preparedness, Rx Policy in Budget Reconciliation","BARDA/DoD Procurements, COVID-19 Response, Pandemic Preparedness, Rx Policy in Budget Reconciliation","Reimbursement of COVID-19 Therapeutics","Pandemic Preparedness"]}